
Overview
Dr. Lechner is a graduate of the University of California at Los Angeles School of Medicine. He completed his oncology and hematology training at Oregon Health & Science University in Portland. Dr. Lechner is board certified in medical oncology and internal medicine.
Dr. Lechner is rated as an Advanced provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Paget Disease of the Breast, and Waldenstrom Macroglobulinemia.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- EPO
- PPO
- PPO
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- PPO
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4525 3rd Avenue Southeast, Suite 200, Lacey, WA
413 Lilly Road Northeast, Olympia, WA 98506
914 South Scheuber Road, Centralia, WA 98531
Additional Areas of Focus
Dr. Lechner has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
The Association Of University Physicians
Christina Baik is an Oncologist and a Hematologist Oncology provider in Seattle, Washington. Dr. Baik is rated as an Elite provider by MediFind in the treatment of Lung Cancer. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Baik is currently accepting new patients.
Medical Oncology - Swedish Cancer Institute First Hill
Dr. Devarakonda trained and worked on faculty at the Washington University in St. Louis before joining Swedish. His research is focused on understanding cancers utilizing sequencing technologies. He has an excellent understanding of the latest advances in thoracic oncology (lung cancer, thymic malignancies, mesothelioma). He believes in providing the same level of care for his patients that he expects for his own family. His list of peer-reviewed scientific publications can be accessed here https://pubmed.ncbi.nlm.nih.gov/?term=Devarakonda+S&cauthor_id=34591593. Dr. Devarakonda is rated as a Distinguished provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.
Medical Oncology - Swedish Cancer Institute First Hill
Cancer is a terrible disease—often one of the most frightening and uncertain experiences a person can face. My philosophy is to approach every patient with a blend of deep empathy and evidence-based treatment options, empowering them to make informed decisions that align with their values, needs, and goals. I believe that compassionate care and scientific rigor form the foundation of meaningful, personalized cancer care. Dr. Santana is rated as a Distinguished provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Colorectal CancerDr. Lechner isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Lechner isDistinguished. Learn about Familial Colorectal Cancer.
- Paget Disease of the BreastDr. Lechner isDistinguished. Learn about Paget Disease of the Breast.
- Waldenstrom MacroglobulinemiaDr. Lechner isDistinguished. Learn about Waldenstrom Macroglobulinemia.
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Lechner isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- AngiosarcomaDr. Lechner isAdvanced. Learn about Angiosarcoma.
- Appendix CancerDr. Lechner isAdvanced. Learn about Appendix Cancer.
- Breast CancerDr. Lechner isAdvanced. Learn about Breast Cancer.
- Chronic B-Cell Leukemia (CBCL)Dr. Lechner isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Adult Soft Tissue SarcomaDr. Lechner isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Lechner isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anal CancerDr. Lechner isExperienced. Learn about Anal Cancer.
- Anaplastic Large Cell LymphomaDr. Lechner isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- AnemiaDr. Lechner isExperienced. Learn about Anemia.

